STRYKER

2012 Annual Report on Form 10-K

Issue link: http://catalog.e-digitaleditions.com/i/114936

Contents of this Issue

Navigation

Page 44 of 49

ITEM 9B. OTHER INFORMATION. Not applicable. PART III ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE. Information regarding our directors and certain corporate governance and other matters appearing under the captions "Information About the Board of Directors and Corporate Governance Matters," "Proposal 1���Election of Directors," "Audit Committee" and "Additional Information���Section 16(a) Beneficial Ownership Reporting Compliance" in the 2013 proxy statement is incorporated herein by reference. The names and ages of our executive officers as of January 31, 2013, the positions they held on that date and the year they first became an executive officer are: Name Age Kevin A. Lobo Steven P. Benscoter Dean H. Bergy Lonny J. Carpenter David K. Floyd Curtis E. Hall Tony M. McKinney Katherine A. Owen Timothy J. Scannell Ramesh Subrahmanian 47 45 53 51 52 56 43 42 48 51 Position President and Chief Executive Officer Vice President, Human Resources Interim Chief Financial Officer and Vice President, Corporate Secretary Group President, Global Quality and Operations Group President, Orthopaedics Vice President and General Counsel Vice President, Chief Accounting Officer Vice President, Strategy and Investor Relations Group President, MedSurg and Neurotechnology Group President, International First Became an Executive Officer 2011 2012 2003 2008 2012 2004 2008 2007 2008 2011 Each of our executive officers named above was elected by our Board of Directors to serve in the office indicated until the first meeting of the Board of Directors following the annual meeting of shareholders in 2013 or until a successor is chosen and qualified or until their resignation or removal. Each of our executive officers has held the position above or has served Stryker in various executive or administrative capacities for at least five years, except for Mr. Lobo, Mr. Floyd and Mr. Subrahmanian. Prior to joining Stryker in April 2011, Mr. Lobo held a variety of senior level leadership roles at Johnson & Johnson for the previous nine years, the most recent being Worldwide President of Ethicon Endo-Surgery. Mr. Subrahmanian, prior to joining Stryker in September 2011, held a variety of senior level leadership roles with Merck & Co. Inc., for the previous five years, most recently as Senior Vice President & President, Asia Pacific Human Health. Mr. Floyd, prior to joining Stryker in November 2012, held a variety of senior level leadership roles with DePuy (a division of Johnson & Johnson), Abbott Spine, AxioMed Spine, Centerpulse Orthopaedics and most recently was Chief Executive Officer for OrthoWorx. The Corporate Governance Guidelines adopted by our Board of Directors, as well as the charters of each of the Audit Committee, the Finance Committee, the Governance and Nominating Committee, the Compensation Committee and the Code of Ethics applicable to the principal executive officer, principal financial officer and principal accounting officer or controller or persons performing similar functions are available, free of charge, under the "Investors���Corporate Governance" section of our website at www.stryker.com. Print copies of such documents are available, free of charge, upon written request sent to the Corporate Secretary of Stryker Corporation at 2825 Airview Boulevard, Kalamazoo, Michigan 49002. ITEM 11. EXECUTIVE COMPENSATION. Information regarding the compensation of our management appearing under the captions "Compensation Discussion and Analysis," "Compensation Committee Report," "Executive Compensation" and "Compensation of Directors" in the 2013 proxy statement is incorporated herein by reference. ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS. The information under the caption "Stock Ownership" in the 2013 proxy statement is incorporated herein by reference. At December 31, 2012, we had equity compensation plans under which options are granted at a price not less than fair market value at the date of grant and under which awards of restricted stock units and performance stock units have been made. These equity 43

Articles in this issue

Links on this page

view archives of STRYKER - 2012 Annual Report on Form 10-K